SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001390478-16-000134
Filing Date
2016-08-09
Accepted
2016-08-09 16:57:11
Documents
72
Period of Report
2016-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gale-20160630x10q.htm 10-Q 1165715
2 EXHIBIT 31.1 gale20160630ex311.htm EX-31.1 8523
3 EXHIBIT 31.2 gale20160630ex312.htm EX-31.2 8650
4 EXHIBIT 32.1 gale20160630ex321.htm EX-32.1 7238
11 logo-verticala10.jpg GRAPHIC 21485
12 logo-verticala11.jpg GRAPHIC 21485
13 pipeline8092016.jpg GRAPHIC 52112
  Complete submission text file 0001390478-16-000134.txt   7194804

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT gale-20160630.xml EX-101.INS 1381964
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT gale-20160630.xsd EX-101.SCH 72395
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT gale-20160630_cal.xml EX-101.CAL 72084
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT gale-20160630_def.xml EX-101.DEF 329514
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT gale-20160630_lab.xml EX-101.LAB 821954
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT gale-20160630_pre.xml EX-101.PRE 495523
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Filer) CIK: 0001390478 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33958 | Film No.: 161818744
SIC: 2834 Pharmaceutical Preparations